熱門資訊> 正文

Vir Biotechnology定价1.5亿美元

2026-02-26 15:22

Vir Biotechnology(VIR) 0
Bullish(BLSH) 0

Vir Biotechnology (VIR) priced its public offering of ~17.65M shares of common stock at $8.50 per share.
Gross proceeds are expected to be about $150M.
The underwriters have a 30-day option to buy up to 2.65M additional shares.
The offering is expected to close on February 27, 2026.
The stock price dropped 2.9% on Wednesday during after-market hours of trading.

More on Vir Biotechnology

Vir Biotechnology: Up On Prostate Data And Astellas Deal - I'm (Long-Term) Bullish
Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript
Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation
Vir Biotechnology launches $200M public stock offering
Vir Biotechnology outlines $1.7B Astellas collaboration and anticipates cash runway into Q2 2028 as VIR-5500 advances

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。